Nico Diederich to Humans
This is a "connection" page, showing publications Nico Diederich has written about Humans.
Connection Strength
0.369
-
The Evolution-Driven Signature of Parkinson's Disease. Trends Neurosci. 2020 07; 43(7):475-492.
Score: 0.040
-
Parkinson's disease: Is it a consequence of human brain evolution? Mov Disord. 2019 04; 34(4):453-459.
Score: 0.037
-
Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease. Mov Disord. 2016 Jan; 31(1):11-22.
Score: 0.029
-
Are patients with Parkinson's disease blind to blindsight? Brain. 2014 Jun; 137(Pt 6):1838-49.
Score: 0.026
-
Hallucinations in Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):331-42.
Score: 0.019
-
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology. 2008 Aug 26; 71(9):677-84.
Score: 0.018
-
Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry. 2008 Jun; 23(6):598-603.
Score: 0.017
-
Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord. 2006 Mar; 21(3):390-4.
Score: 0.015
-
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord. 2005 Feb; 20(2):130-40.
Score: 0.014
-
Coping strategies for visual hallucinations in Parkinson's disease. Mov Disord. 2003 Jul; 18(7):831-2.
Score: 0.012
-
Understanding visual hallucinations: A new synthesis. Neurosci Biobehav Rev. 2023 07; 150:105208.
Score: 0.012
-
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003 Apr; 60(4):529-33.
Score: 0.012
-
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002 Aug; 59(8):1249-52.
Score: 0.012
-
Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol. 2000 Sep-Oct; 23(5):287-9.
Score: 0.010
-
Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease. Brain Cogn. 2000 Mar; 42(2):294-306.
Score: 0.010
-
[Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]. Fortschr Neurol Psychiatr. 2000 Mar; 68(3):129-36.
Score: 0.010
-
Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):289-95.
Score: 0.009
-
Drug-induced movement disorders. Neurol Clin. 1998 Feb; 16(1):125-39.
Score: 0.009
-
Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia: a 2-year follow-up study. Mov Disord. 1997 Nov; 12(6):1100-2.
Score: 0.008
-
[Botulin toxin: principles of action and neurological indications]. Presse Med. 1997 Feb 01; 26(2):96-100.
Score: 0.008
-
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol. 1996 Sep; 40(3):463-5.
Score: 0.008
-
There is a renaissance of interest in pallidotomy for Parkinson's disease. Nat Med. 1996 May; 2(5):510-4.
Score: 0.008
-
[Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results]. Bull Soc Sci Med Grand Duche Luxemb. 1993; 130(1):25-36.
Score: 0.006
-
Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology. 1992 Jul; 42(7):1311-4.
Score: 0.006
-
Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May; 10(2):527-40.
Score: 0.006
-
New approaches in the treatment of the dystonias. Klin Wochenschr. 1990 Oct 03; 68(19):935-41.
Score: 0.005
-
Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci. 2000 Jan 01; 172(1):7-11.
Score: 0.002
-
Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology. 1998 Aug; 51(2):526-9.
Score: 0.002